Maja Pawinska Sims 11 May 2022 // 12:37PM GMT
LONDON — The world’s largest independent dermatology company, Galderma, has selected Brands2Life to manage UK communications for its Cetaphil and Acnecide brands after a competitive pitch.
The brief includes a programme for Cetaphil, which has been used to treat sensitive skin for 75 years, as well as a campaign for teenage acne treatment Acnecide to dispel myths around acne, alongside a new product launch this year.
Galderma’s head of consumer marketing Caroline Leaf said: “The year ahead has many exciting moments for both Cetaphil and Acnecide as we continue to advance our skincare story and we’re delighted to be working with Brands2Life to ensure our brands are well known and understood.”
Brands2Life’s health and wellbeing MD Emily Thomas added: “Galderma’s legacy and expertise in developing premium skin care products is truly impressive and we’re thrilled to be working together. For people with sensitive or acne prone skin, having the right skin care product can be transformative, so building consumer awareness and skin understanding will be at the heart of our work.”
Galderma joins other consumer healthcare brands OTC, contraception, probiotics, eye care and mental health in Brands2Life’s fast-growing health and wellbeing practice.